NSCLC immunization ‘proof of concept’ achieved

Immunization against MAGE-A3 is a feasible adjuvant treatment in patients with resectable non-small-cell lung cancer expressing the tumor-specific antigen, research suggests.
Source: MedWire News - Respiratory - Category: Respiratory Medicine Source Type: news